Wells Fargo raised the firm’s price target on Cardinal Health (CAH) to $136 from $135 and keeps an Equal Weight rating on the shares. The firm is also increasing its estimates following Q2 results to reflect modestly higher core earnings and the closing of the GIA acquisition.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CAH: